A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
A Lasting Impact: COVID-19 and Cancer Screening
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
How the Roe v. Wade Ruling Will Impact Prenatal Testing
Without abortion rights, basic lab testing applications for those who are or want to become pregnant have new and ominous legal implications.
ML Model Predicts Cancer Patient Response to Immunotherapy
New tool helps determine whether immunotherapy is a better option for patients than chemotherapy or radiotherapy.
GAO: FDA Needs Policy to Avoid Repeating EUA COVID-19 Test Mistakes
In a recent report, the GAO says the agency needs a policy when it comes to enforcement discretion regarding tests approved via EUA.
AI and Wearable Devices Offer Promise as an Early COVID-19 ID Method
While still in its infancy, recent research shows the combination of AI and wearables can accurately detect early SARS-CoV-2 infection.
Liquid Biopsy Can Rule Out Need for Chemotherapy After Stage II Colon Cancer Surgery
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
Leveraging COVID-19 Testing Infrastructure Can Boost Diabetes Screening
A new study suggests that this is a viable idea, particularly in the context of diabetes screening in a Latinx community.
Smart Inhalers May Enable Better Management of Respiratory Disorders
Inhalers and sensors that offer digital monitoring are beginning to gain FDA approval, and could solve usage issues of traditional products.
Genomic Biomarker Tests Endorsed for Early Prostate Cancer Management
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.
FDA Re-Opens Door to Pre-Submission Requests for Non-COVID-19 IVD Tests
The move comes shortly after the FDA said it was going to decline some pre-submission requests to focus on pandemic-related diagnostics.
Study Offers More Insight on Pandemic’s Disruption to Cancer Screening
New research led by the American Cancer Society shows decreases in cervical and breast cancer screening during the pandemic.
